Related Experiment Video
Updated: Jun 8, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages
Nadia L Ferrer1, Ana B Gomez, Olivier Neyrolles
1Grupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza, Zaragoza, Spain.
Background:
Mycobacterium tuberculosis phoP mutant SO2 derived from a clinical isolate was shown to be attenuated in mouse bone marrow-derived macrophages and in vivo mouse infection model and has demonstrated a high potential as attenuated vaccine candidate against tuberculosis.
Methodology/Principal Findings:
In this study, we analyze the adhesion and the intracellular growth and trafficking of SO2 in human macrophages. Our results indicate an enhanced adhesion to phagocitic cells and impaired intracellular replication of SO2 in both monocyte-derived macrophages and human cell line THP-1 in comparison with the wild type strain, consistent with murine model. Intracellular trafficking analysis in human THP-1 cells suggest that attenuation of SO2 within macrophages could be due to an impaired ability to block phagosome-lysosome fusion compared with the parental M. tuberculosis strain. No differences were found between SO2 and the wild-type strains in the release and mycobacterial susceptibility to nitric oxide (NO) produced by infected macrophages.
Conclusions/Significance:
SO2 has enhanced ability to bind human macrophages and differs in intracellular trafficking as to wild-type M. tuberculosis. The altered lipid profile expression of the phoP mutant SO2 and its inability to secrete ESAT-6 is discussed.
Insights
The Mycobacterium tuberculosis phoP mutant SO2 shows increased binding to human macrophages and reduced intracellular growth, suggesting potential as an attenuated tuberculosis vaccine candidate.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Mycobacterium tuberculosis (M. tuberculosis) phoP mutant SO2, derived from a clinical isolate, is attenuated in murine models.
- This attenuation suggests SO2's potential as a live-attenuated vaccine candidate against tuberculosis.
Purpose of the Study:
- To investigate the adhesion, intracellular replication, and trafficking of M. tuberculosis SO2 in human macrophages.
- To compare SO2's behavior with the wild-type M. tuberculosis strain in a human cellular context.
Main Methods:
- Analysis of SO2 adhesion to human monocyte-derived macrophages and THP-1 cells.
- Assessment of intracellular replication and trafficking of SO2 within human macrophages.
- Comparison of SO2 with wild-type M. tuberculosis regarding nitric oxide (NO) susceptibility.
Main Results:
- SO2 exhibited enhanced adhesion to human phagocytic cells compared to the wild-type strain.
- Impaired intracellular replication of SO2 was observed in both monocyte-derived macrophages and THP-1 cells.
- Intracellular trafficking analysis indicated SO2 has an impaired ability to block phagosome-lysosome fusion.
Conclusions:
- M. tuberculosis SO2 demonstrates enhanced binding to human macrophages and altered intracellular trafficking.
- The study discusses the altered lipid profile and ESAT-6 secretion of the phoP mutant SO2 in relation to its attenuation.
- Findings support SO2's potential as an attenuated vaccine candidate against tuberculosis.
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

